Seaport Global Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Seaport Global Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$882K	Hold	839	–	–	2.79%	10
2024 Q2	$882K	Buy	839 +328	+64%	+$318K	3.16%	8
2024 Q1	$492K	Buy	+511	New	+$486K	1%	43
2023 Q4	–	Sell	-251	Closed	-$207K	–	90
2023 Q3	$207K	Sell	251 -478	-66%	-$376K	0.62%	58
2023 Q2	$524K	Buy	729 +115	+19%	+$88.7K	1.54%	18
2023 Q1	$505K	Buy	614 +136	+28%	+$103K	1.59%	15
2022 Q4	$345K	Hold	478	–	–	1.2%	27
2022 Q3	$329K	Buy	478 +32	+7%	+$20.1K	1.34%	16
2022 Q2	$264K	Sell	446 -61	-12%	-$39.7K	0.98%	35
2022 Q1	$354K	Sell	507 -1,087	-68%	-$688K	1.13%	32
2021 Q4	$1.01M	Buy	+1,594	New	+$980K	1.36%	28

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Seaport Global Advisors's REGN Position: Q3 2024 in Review

Seaport Global Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2024 at 839 shares worth $882K. The position accounts for 2.79% of the portfolio, ranked #10.

Seaport Global Advisors first reported a position in REGN in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.01M in Q4 2021. 1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Seaport Global Advisors held 839 shares of Regeneron Pharmaceuticals worth $882K as of Q3 2024.
Seaport Global Advisors left its Regeneron Pharmaceuticals share count unchanged in Q3 2024.
Regeneron Pharmaceuticals made up 2.79% of Seaport Global Advisors's portfolio in Q3 2024, its #10 holding.
Seaport Global Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
Seaport Global Advisors's Regeneron Pharmaceuticals position peaked at $1.01M in Q4 2021.
1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Seaport Global Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.